Rating History for Prevail Therapeutics (PRVL) by Stifel

More Stocks Rated by Stifel | Latest Ratings for PRVL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/17/2020 Paul Matteis Downgrade Hold
(Buy)		 23.00
(N/A)		 22.75
(23.00)		 1.1% Details